DRTG(SH:600329) Xin Lang Zheng Quan·2025-11-12 05:43Core Viewpoint - Daren Tang's stock price has shown significant volatility, with a recent decline of 2.02%, while the company has experienced a substantial increase in stock price of 66.12% year-to-date [1][2]. Company Overview - Daren Tang, established on December 29, 1981, and listed on June 6, 2001, is located in Tianjin, China. The company operates in various sectors including traditional Chinese medicine, drug retail, and biopharmaceuticals [2]. - The main revenue sources for Daren Tang are traditional Chinese medicine (91.47%), other main income (6.54%), Western medicine (1.77%), and other (0.22%) [2]. Financial Performance - For the period from January to September 2025, Daren Tang reported a revenue of 3.67 billion yuan, a year-on-year decrease of 34.59%. However, the net profit attributable to shareholders increased by 167.73% to 2.15 billion yuan [2]. - The company has distributed a total of 5.12 billion yuan in dividends since its A-share listing, with 2.83 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 7.46% to 58,600, with an average of 9,675 circulating shares per person, a decrease of 6.94% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 500 ETF, with changes in their holdings noted [3].